Pharmaceutical company: Boehringer cancels investments of 900 million euros in Germany
—·23d
The pharmaceutical company Boehringer Ingelheim is withdrawing investment plans in Germany. The reason is poorer general conditions and the planned austerity law in the healthcare system.
Channelscurrencies, semiconductors, stocksCountriesgermany, europe, ukCategoriescurrencies
Open original source ↗Published
6/3/2026, 1:24:00 PM
Fetched
6/3/2026, 3:07:48 PM
Confidence
60 / 100
Relevance
35 / 100
Trust
—
Language
de